IL17A and psoriasis: These alterations in metabolite production and anti-microbial signaling can affect immune cell activation through the IL-23/IL-17 signaling pathway, shedding light on the mechanism of increased inflammation in Psoriasis, in addition to the crucial roles of autoreactive T cells and proinflammatory cytokines, which occur in the disease.